Knowridge: New blood clues may show why Alzheimer’s disease develops

Alzheimer’s disease is one of the most feared illnesses of aging. It slowly damages memory, thinking, and behavior, and over time it makes it difficult for people to carry out everyday tasks.

For decades, scientists have focused mainly on one key feature of the disease: sticky clumps of a protein called amyloid that build up in the brain. These clumps, known as plaques, have long been seen as a major cause of Alzheimer’s. However, new research suggests that the story is much more complex.

Researchers at the Emory Goizueta Brain Health Institute and several partner institutions have discovered new clues in the blood that may help explain why Alzheimer’s develops and how it affects memory.

The study was published in the journal Nature Aging. It involved more than 2,100 people from four large research groups. By studying blood samples from these participants, scientists were able to measure thousands of different proteins and examine how they were linked to changes in memory and thinking ability.

Proteins are small building blocks in the body that carry out many important tasks. They help cells communicate, produce energy, fight infection, and repair damage.

In this study, researchers used advanced laboratory tools to look at patterns of proteins circulating in the blood. They then compared these patterns with brain changes and cognitive performance in the participants.

The results showed that Alzheimer’s disease is connected to many processes beyond amyloid plaques. The researchers found that proteins related to the immune system were strongly linked to memory problems. This suggests that inflammation and immune responses may play a larger role in Alzheimer’s than previously thought.

They also identified proteins involved in how cells break down and remove waste, a process sometimes called protein disposal. When this system does not work properly, harmful materials can build up in the body.

In addition, proteins tied to energy production were connected to changes in thinking ability. The brain uses a great deal of energy to function. If the body’s energy systems are not working efficiently, brain cells may struggle to do their jobs.

The researchers also found changes in proteins related to the extracellular matrix, which is the network that provides structure and support to cells. This network helps maintain the stability of tissues, including the brain.

One of the most surprising findings was that many of these protein changes could not be fully explained by what doctors usually see in the brain after death.

In other words, some of the processes linked to memory loss may be happening outside the brain. This raises the possibility that organs and systems throughout the body may influence how Alzheimer’s begins and how quickly it progresses.

Dr. Erik Johnson, a senior author of the study and a physician at Emory’s Goizueta Alzheimer’s Disease Research Center, explained that many of the blood proteins identified were not directly connected to the typical brain changes seen in Alzheimer’s.

This suggests that overall body health could play an important role in disease risk. It may also help explain why some people decline faster than others.

The study included participants from several major research efforts, including Emory University Alzheimer’s studies, the Bio-Hermes study, the Religious Orders Study, and the Rush Memory and Aging Project. These large groups allowed scientists to analyze data from people with different backgrounds and stages of disease, strengthening the reliability of the findings.

The results could have important practical benefits. Currently, diagnosing Alzheimer’s often requires brain scans or spinal fluid tests, which can be expensive or uncomfortable.

If blood proteins can provide reliable signals of disease, doctors may one day use simple blood tests to detect Alzheimer’s earlier and track its progress over time. This would make monitoring the disease easier and more accessible.

In reviewing and analyzing the study, several strengths stand out. The large number of participants increases confidence in the results. The use of advanced technology allowed researchers to examine thousands of proteins at once, providing a broad view of the body’s biology.

Importantly, the study moves beyond the narrow focus on amyloid and highlights the complex nature of Alzheimer’s disease.

However, the research also raises new questions. While the study shows strong links between certain blood proteins and memory decline, it does not prove that these proteins directly cause Alzheimer’s.

More research will be needed to determine whether changing these pathways can slow or prevent the disease. Long-term studies and clinical trials will be essential to confirm these findings and translate them into treatments.

Overall, this research suggests that Alzheimer’s disease is not only a brain disorder but may involve the whole body. By looking beyond plaques and considering immune health, energy balance, and other biological systems, scientists are gaining a more complete understanding of the illness.

This broader view may open the door to new treatment strategies that target blood-based pathways instead of focusing only on the brain.

As researchers continue to explore these discoveries, blood testing may become an important tool in the fight against Alzheimer’s. Early detection and better understanding of the disease’s many pathways could ultimately lead to more effective and personalized care for millions of people worldwide.

If you care about Alzheimer’s, please read studies about Vitamin D deficiency linked to Alzheimer’s, vascular dementia, and Oral cannabis extract may help reduce Alzheimer’s symptoms.

For more information about brain health, please see recent studies about Vitamin B9 deficiency linked to higher dementia risk, and results showing flavonoid-rich foods could improve survival in Parkinson’s disease.